ESTRELLA IMMUNOPHARMA, INC. Earnings Per Share (Basic)
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Earnings Per Share (Basic) of -$0.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- ESTRELLA IMMUNOPHARMA, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.05.
- ESTRELLA IMMUNOPHARMA, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.05.
- ESTRELLA IMMUNOPHARMA, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.02.
- ESTRELLA IMMUNOPHARMA, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.13.
- ESTRELLA IMMUNOPHARMA, INC. earnings per share, basic for fiscal 2025 was -$0.35.
- ESTRELLA IMMUNOPHARMA, INC. earnings per share, basic for fiscal 2024 was -$0.27.
- ESTRELLA IMMUNOPHARMA, INC. earnings per share, basic for fiscal 2023 was -$36.35.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.05 10-Q · filed 2026-08-13 | -$0.11 10-Q · filed 2026-08-13 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-13 | |
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-18 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-08-13 | |
| 2025-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2026-03-18 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-03-18 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.35 10-K · filed 2026-03-18 | |
| 2025-09-30 | -$0.13 10-Q · filed 2025-11-12 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.34 10-Q · filed 2025-11-12 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-08-13 | |
| 2025-06-30 | -$0.15 10-Q · filed 2026-08-13 | -$0.21 10-Q · filed 2026-08-13 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-08-13 | |
| 2025-03-31 | -$0.06 10-Q · filed 2026-05-18 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-08-13 | |
| 2024-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-03-18 | -$0.12 10-K · filed 2026-03-18 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-03-18 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-03-18 | |
| 2024-09-30 | -$0.09 10-Q · filed 2025-11-12 | -$0.20 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.22 10-Q · filed 2025-11-12 | -$0.25 derived: net income ÷ weighted average shares · filed 2025-11-12 | |
| 2024-06-30 | -$0.11 10-Q · filed 2025-08-12 | -$0.12 10-Q · filed 2025-08-12 | -$0.15 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.27 10-KT · filed 2025-03-25 | |
| 2024-03-31 | -$0.01 10-Q · filed 2025-05-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.14 10-Q · filed 2024-05-15 | -$0.19 derived: net income ÷ weighted average shares · filed 2025-11-12 | |
| 2023-12-31 | -$0.03 10-Q · filed 2024-02-14 | -$0.16 10-Q · filed 2024-02-14 | -$0.24 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.61 derived: net income ÷ weighted average shares · filed 2024-11-14 | |
| 2023-09-30 | -$1.78 10-Q · filed 2024-11-14 | -$2.36 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$7.09 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$13.83 derived: net income ÷ weighted average shares · filed 2024-11-14 | |
| 2023-06-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2024-09-27 | -$0.30 derived: net income ÷ weighted average shares · filed 2024-09-27 | -$15.21 derived: net income ÷ weighted average shares · filed 2024-09-27 | -$36.35 10-K · filed 2024-09-27 | |
| 2023-03-31 | -$8.13 10-Q · filed 2024-05-15 | -$21.73 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$39.95 10-Q · filed 2024-05-15 | -$17.40 derived: net income ÷ weighted average shares · filed 2024-05-15 | |
| 2022-12-31 | -$16.33 10-Q · filed 2024-02-14 | -$44.63 10-Q · filed 2024-02-14 | -$10.76 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$1.29 derived: net income ÷ weighted average shares · filed 2024-02-14 | |
| 2022-09-30 | -$34.33 10-Q · filed 2023-11-20 | -$0.08 10-Q · filed 2022-11-14 | -$4.32 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$0.17 10-Q · filed 2022-11-14 | -$3.24 derived: net income ÷ weighted average shares · filed 2024-05-15 |
| 2022-06-30 | -$0.06 10-Q · filed 2022-08-08 | -$0.09 10-Q · filed 2022-08-08 | -$0.45 derived: net income ÷ weighted average shares · filed 2023-08-01 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-08-01 | |
| 2022-03-31 | -$0.02 10-Q · filed 2022-05-16 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-08-01 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-08-01 | -$0.30 derived: net income ÷ weighted average shares · filed 2023-08-01 | |
| 2021-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.18 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$0.21 derived: net income ÷ weighted average shares · filed 2023-03-14 | |
| 2021-09-30 | -$0.99 10-Q · filed 2022-11-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$2.06 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | -$2.06 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |